Status:
COMPLETED
Noninvasive Dual-mode Stimulation Therapy for Neurorehabilitation in Stroke
Lead Sponsor:
Samsung Medical Center
Conditions:
Stroke
Eligibility:
All Genders
19+ years
Phase:
NA
Brief Summary
Repetitive transcranial magnetic stimulation (rTMS) or transcranial direct current stimulation (tDCS) has been used for the modulation of stroke patients' motor function by altering the cortical excit...
Eligibility Criteria
Inclusion
- First-ever stroke patients
- Subacute stage (less than 4 weeks)
- Total Fugl-Meyer Assessment (FMA) score under 84
Exclusion
- Major active neurological disease or psychiatric disease
- A history of seizure
- Metallic implants in their brain
Key Trial Info
Start Date :
January 13 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 13 2018
Estimated Enrollment :
43 Patients enrolled
Trial Details
Trial ID
NCT03390192
Start Date
January 13 2015
End Date
March 13 2018
Last Update
September 19 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Samsung Medical Center
Seoul, South Korea